Previously doing business as Princeton Trade & Technology, Inc., Novaflux Technologies is anchored in development of technologies for removing biofilm and other contaminants from medical and industrial equipment and devices. Devices have been developed to remove biofilm from dental unit waterlines, for hemodialyzer reprocessing, endoscope reprocessing and cold sterilization of dental handpieces. With patents pertaining to the turbulent two-phase cleaning process and its applications Novaflux Technologies Inc is actively developing new applications for its breakthrough two-phase flow cleaning technology platform. Novaflux Technologies Inc's focus has been to improve the quality of life and treatment outcomes of the millions of people who currently undergo dialysis or are at risk for becoming chronic renal disease patients. Their patented technologies address unmet needs in hemodialysis and reduce the overall cost of treatment while delivering better patient outcomes. Additionally, NovaFlux is working to prevent cross-infection in patients undergoing endoscopic procedures. More than 25% of hepatitis C infections are believed to be caused by endoscopic procedures, and the endoscope reprocessing technology is the first automated system to completely clean and sterilize the exterior shield and the internal channels of endoscopes.
